Health knowledge made personal
Please enter a search word or phrase.
The search word cannot have more than 100 characteres.
Head And Neck Cancer - Articles
PET surveillance for head and neck cancer
by
Mark Levin
Posted
Sun 13 Dec 2009 8:08am
The question is about the appropriate followup of head and neck cancer. This is surveillance rather than restaging. NCCN on p. 42, to which one is directed by links from... in patients with treated head and neck cancer and available retrospective data are conflicting.
The detection of residual disease after therapy is a particularly difficult problem
Read on »
Coffee Might Guard Against Head, Neck Cancers
by
nutrition.gov
Posted
Fri 18 Jun 2010 5:00am
HealthDay
By Robert Preidt
Friday, June 18, 2010
FRIDAY, June 19 (HealthDay News) -- Coffee may help protect against head and neck cancers, a new review finds.
Researchers analyzed nine studies collected by the International Head and Neck Cancer Epidemiology consortium. They found that regular coffee drinkers (four
Read on »
Cisplatin etoposide for head and neck cancer
by
Mark Levin
Posted
Tue 26 Oct 2010 1:56am
Cisplatin and etoposide has been reported for the treatment of recurrent head and neck cancer but it is not a well-supported regimen or one that has been popular over teh.... Goldine, J. M. Connors, K. Gelmon, M. A. Knowling Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neck cancer
Ann Oncol (1992) 3 (suppl 3
Read on »
Tarceva for head and neck cancer
by
Mark Levin
Posted
Wed 25 Nov 2009 10:03pm
and neck cancer, for example, Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA), NCT00304278. The purpose of this study is to determine the safety and effectiveness of treatment with Tarceva (Erlotinib) and RADPLAT (RADiation and intraaterial cisPLATin) for patients with Head and Neck cancer. There is also: A Study
Read on »
Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
by
Aarkstore
Posted
Mon 19 Apr 2010 4:10am
The industry analysis specialist, has released its new report, “Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016”. The report is an essential source of information and analysis on the global head and neck cancer market. The report identifies the key trends shaping and driving the global head and neck cancer market. It also provides
Read on »
Delay in diagnosis of head and neck cancer
by
Mark Levin
Posted
Thu 01 Jul 2010 5:25am
Diagnosis and treatmetn of head and neck cancer is complex and requires co-ordination or providers and resources. Delays in diagnosis is not uncommon. In a Canadian study... cancers.J Can Dent Assoc. 2008 Feb;74(1):61
Goy J, Hall SF, Feldman-Stewart D, Groome PA. Diagnostic delay and disease stage in head and neck cancer: a systematic review
Read on »
Carboplatin for chemoradiation for head and neck cancer
by
Mark Levin
Posted
Thu 13 Aug 2009 7:39pm
)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.Oncologist. 2003;8(1):35-44.
nccn.org, head and neck
Eckardt...:11-3.
AGARWALA S. S. et al, Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer Annals
Read on »